Immunodeficiency of aging

Drugs and Aging

Volumn 11, Issue 5, 1997, Pages 374-397

  Burns, Edith A ^a   Goodwin, James S ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CYTOKINE; PROSTAGLANDIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; ETIOLOGY; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; INFLUENZA; MACROPHAGE; NATURAL KILLER CELL; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; T LYMPHOCYTE ACTIVATION; TETANUS; TUBERCULOSIS;

EID: 0030728939     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199711050-00005     Document Type: Review

References (259)

1. Roberts-Thompson IC, Whittingham S, Young-Chaiyud U, et al. Aging, immune response and mortality. Lancet 1974; II: 368-70
2. Goodwin JS, Searles RP, Tung KSK. Immunological responses of a healthy elderly population. Clin Exp Immunol 1982; 48: 403-10
3. Hess EV, Knapp D. The immune system and aging: a case of the cart before the horse. J Chronic Dis 1978; 31: 647-9
4. Miller RA. Aging and immune function. Int Rev Cytol 1991; 124: 187-215
5. Philosophe B, Miller RA. Diminished calcium signal generation in subsets of T lymphocytes that predominate in old mice. J Gerontol 1990; 45: B87-93
6. Nijhuis EW, Remarque EJ, Hinloopen B, et al. Age-related increase in the fraction of CD27-CD4+ T cells and IL-4 production as a feature of CD4+ T cell differentiation in vivo. Clin Exp Immunol 1994; 96: 528-34
7. Jackola DR, Ruger JK, Miller RA. Age-associated changes in human T cell phenotype and function. Aging 1994; 6: 25-34
8. Xu X, Beckman I, Ahern M, et al. A comprehensive analysis of peripheral blood lymphocytes in healthy aged humans by flow cytometry. Immunol Cell Biol 1993; 71: 549-57
9. Kudlacek S, Jahandideh-Kazempour S, Graninger W, et al. Differential expression of various T cell surface markers in young and elderly subjects. Immunobiology 1995; 192: 198-204
10. Jackola DR, Ruger JK, Miller RA. Age-associated changes in human T cell phenotype and function. Aging 1994; 6: 25-34
11. Dobber R, Tielemans M, Nagelkerken L. Enrichment for ThI cells in the Mel-14+ CD4+ T cell fraction in aged mice. Cell Immunol 1995; 162: 321-5
12. Dobber R, Tielemans M, de Weerd H, et al. Mell4+CD4+ T cells from aged mice display functional and phenotypic characteristics of memory cells. Int Immunol 1994; 6: 1227-34
13. Murasko DM, Weiner P, Kaye D. Association of lack of mitogen-induced lymphocyte proliferation with increased mortality in the elderly. Aging Immunol Infect Dis 1988; 1: 1-6
14. Inkeles B, Innes JB, Kuntz MM, et al. Immunological studies of aging: III. Cytokinetic basis for the impaired response of lymphocytes from ased humans to plant lectins. J Exp Med 1977; 145: 1176-87
15. Goodwin JS, Messner RP. Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70. J Clin Invest 1979; 64: 434-9
16. Kirschmann DA, Murasko DM. Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli. Cell Immunol 1992; 139: 426-37
17. Ernst DN, Weigle WO, McQuitty DN, et al. Stimulation of murine T cell subsets with anti-CD3 antibody: age-related defects in the expression of early activation molecules. J Immunol 1989; 142: 1413-21
18. Vissinga C, Nagelkerken L, Sijlstra J, et al. A decreased functional capacity of CD4+ T cells underlies the impaired DTH reactivity in old mice. Mech Ageing Dev 1990; 53: 127-39
19. Gottesman SRS, Edington J. Proliferative and cytotoxic immune functions in aging mice: V. Deficiency in generation of cytotoxic cells with normal lytic function per cell as demonstrated by the single cell conjugation assay. Aging Immunol Infect Dis 1990; 2: 19-29
20. Kishimoto S, Tomino S, Mitsuya H, et al. Age-related changes in suppressor functions of human T cells. J Immunol 1979; 123: 1586-92
21. Crawford J, Oates S, Wolfe LA, et al. An in vitro analogue of immune dysfunction with altered immunoglobulin production in the aged. J Am Geriatr Soc 1989; 37: 1141-6
22. Grossmann A, Ledbetter JA, Rabinovitch PS. Reduced proliferation in T lymphocytes in aged humans is predominantly in the CD8+ subset and is unrelated to defects in transmembrane signaling which are predominantly in the CD4+ subsets. Exp Cell Res 1989; 180: 367-82
23. Doria G, Mancini C, Frasca D, et al. Age restriction in antigen-specific immunosuppression. J Immunol 1987; 139: 1419-25
24. Russo C, Cherniak EP, Wali A, et al. Age-dependent appearance of non-major histocompatibility complex-restricted helper T cells. Proc Natl Acad Sci U S A 1993; 90: 11718-22
25. Hara H, Negoro S, Miyata S, et al. Age-associated changes in proliferative and differentiative response of human B cells and production of T cell-derived factors regulating B cell functions. Mech Ageing Dev 1987; 38: 245-58
26. Schwab R, Russo C, Weksler ME. Altered major histocompatibility complex-restricted antigen recognition by T cells from elderly humans. Eur J Immunol 1992; 22: 2989-93
27. Zhao KS, Wang YF, Gueret R, et al. Dysregulation of the humoral immune response in old mice. Int Immunol 1995; 7: 929-34
28. Hallgren H, Buckley C, Gilbertson V, et al. Lymphocyte phytohemagglutinin responsiveness, immunoglobulins, and auto-antibodies in aging humans. J Immunol 1973; 111: 1101-7
29. Lewis RS, Cahalan MD. Potassium and calcium channels in lymphocytes. Ann Rev Immunol 1995; 13: 623-53
30. Jayaraman T, Ondriasova E, Ondrias K, et al. The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling. Proc Natl Acad Sci USA 1995; 92: 6007-11
31. 2+ stores. Proc Natl Acad Sci U S A 1993; 90: 6295-9
32. Miller RA, Philosophe B, Ginis I, et al. Defective control of cytoplasmic calcium concentration in T lymphocytes from old mice. J Cell Physiol 1989; 128: 175-82
33. Miller RA. Calcium signals in T lymphocytes from old mice. Life Sci 1996; 59: 469-75
34. Fultop Jr T, Barabas G, Varga Z, et al. Transmembrane signaling changes with aging. Ann N Y Acad Sci 1992; 673: 165-71
35. Philosophe B, Miller RA. Calcium signals in murine T lymphocytes: preservation of response to PHA and to an anti-Ly-6 antibody. Aging Immunol Infect Dis 1990; 2: 11-8
36. Kawanishi H, Ajitsu S, Mirabella S. Impaired humoral immune responses to mycobacterial antigen in aged murine gut-associated lymphoid tissues. Mech Ageing Dev 1990; 54: 143-61
37. Lustyik G, O'Leary JJ. Aging and the mobilization of intracellular calcium by phytohemagglutinin in human T cells. J Gerontol 1989; 44: B30-6
38. Jackola DR, Hallgren HM. Diminished cell-cell binding by lymphocytes from healthy elderly humans: evidence for altered activation of LFA-1 function with age. J Gerontol 1995; 50: B368-77
39. Whisler RL, Newhouse YG, Bagenstose SE. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex. Cell Immunol 1996; 168: 201-10
40. Whisler RL, Newhouse YG, Grants IS, et al. Differential expression of the alpha- and beta-isoforms of protein kinase C in peripheral blood T and B cells from young and elderly adults. Mech Ageing Dev 1995; 77: 197-211
41. Patel HR, Miller RA. Age-associated changes in mitogen-induced protein phosphorylation in murine T lymphocytes. Eur J Immunol 1992; 22: 253-60
42. Shi J, Miller RA. Differential tyrosine-specific protein phosphorylation in mouse T lymphocyte subsets: effect of age. J Immunol 1993; 151: 730-9
43. Whisler RL, Beiqing L, Chen M. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT. Cell Immunol 1996; 169: 185-95
44. Whisler RL, Liu B, Wu LC, et al. Reduced activation of transcriptional factor AP-1 among peripheral blood T cells from elderly humans after PHA stimulation: restorative effect of phorbol diesters. Cell Immunol 1993; 152: 96-109
45. Makinodan T. Biology of aging: retrospect and prospect. In: Makinodan T, Yunis E, editors. Immunology and aging. New York: Plenum Press, 1977: 1-8
46. Callard R, Basten A, Blanden R. Loss of immune competence with age may be due to a qualitative abnormality in lymphocyte membranes. Nature 1979; 281: 218-21
47. Zharhary D. Age-related changes in the capability of the bone marrow to generate B cells. J Immunol 1988; 141: 1863-9
48. Ben-Yehuda A, Szabo P, Dyall R, et al. Bone marrow declines as a site of B-cell precursor differentiation with age: relationship to thymus involution. Proc Natl Acad Sci U S A 1994; 91: 11988-92
49. Viale AC, Chies JA, Huetz F, et al. VH-gene family dominance in ageing mice. Scand J Immunol 1994; 39: 184-8
50. Whisler RL, Grants IS. Age-related alterations in the activation and expression of phosphotyrosine kinases and protein kinase C (PKC) among human B cells. Mech Ageing Dev 1993; 71: 31-46
51. Delafuente JC. Immunosenescence: clinical and pharmacologic considerations. Med Clin North Am 1985; 69: 475-86
52. Arreaza EE, Gibbons Jr JJ, Siskind GW, et al. Lower antibody response to tetanus toxoid associated with higher auto-antiidiotypic antibody in old compared with young humans. Clin Exp Immunol 1993; 92: 169-73
53. Cinader B, Thorbecke GJ. Aging and the immune system: report on workshop #94 held during the 7th International Congress of Immunology; 1989 Aug 3: Berlin. Aging Immunol Infect Dis 1990; 2: 45-53
54. Whittingham S, Buckley JD, Mackay IR. Factors influencing the secondary antibody response to flagellin in man. Clin Exp Immunol 1978; 34: 170-8
55. De Greef GE, Van Staalduinen GJ, Van Doorninck H, et al. Age-related changes of the antigen-specific antibody formation in vitro and PHA-induced T cell proliferation in individuals who met the Senieur protocol. Mech Ageing Dev 1992; 66: 1-14
56. Ligthart GJ, Corberand JX, Fournier C, et al. Admission criteria for immunogerontological studies in man: the Senieur protocol. Mech Ageing Dev 1984; 28: 47-55
57. Kishimoto S, Tomino S, Mitsuya H, et al. Age-related decrease in frequencies of B-cell precursors and specific helper T cells involved in the IgG anti-tetanus toxoid antibody production in humans. Clin Immunol Immunopathol 1982; 25: 1-10
58. Burns EA, Lum LG, Giddings BR, et al. Decreased specific antibody synthesis by lymphocytes from elderly subjects. Mech Ageing Dev 1990; 53: 229-41
59. Burns EA, Lum LG, l'Hommedieu GD, et al. Decreased humoral immunity in aging: in vivo and in vitro response to vaccination. J Gerontol 1993; 48: B231-6
60. Ennist DL, Hones KH, St Pierre RL, et al. Functional analysis of the immunosenescence of the human B cell system: dissociation of normal activation and proliferation from impaired terminal differentiation into IgM immunoglobulin-secreting cells. J Immunol 1986; 136: 99-105
61. Whisler RL, Williams JW, Newhouse YG. Human B cell proliferative responses during aging: reduced RNA synthesis and DNA replication after signal transduction by surface immunoclobulins compared to B cell antigenic determinants CD20 and CD40. Mech Ageing Dev 1991; 61: 209-222
62. Hu A, Ehleiter D, Ben-Yehuda A, et al. Effect of age on the expressed B cell repertoire: role of B cell subsets. Int Immunol 1993; 5: 1035-9
63. Nicoletti C, Yang X, Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice: III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J Immunol 1993; 150: 543-9
64. Miller C, Kelsoe G. Ig VH hypermutation is absent in the germinal centers of aged mice. J Immunol 1995; 155: 3377-84
65. Delfraissey J, Galanaud P, Wallon C, et al. Abolished in vitro antibody response in the elderly: exclusive involvement of prostaglandin-induced T suppressor cells. Clin Immunol Immunopathol 1982; 24: 377-85
66. Delfraissey JF, Galanaud P, Dormont J, et al. Age-related impairment of the in vitro antibody response in the human. Clin Exp Immunol 1980; 39: 208-14
67. McLachlan JA, Serkin CD, Morrey-Clark KM, et al. Immunological functions of aged monocytes. Pathobiology 1995; 63: 148-59
68. Danon D, Kowatch MA, Roth GS. Promotion of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci U S A 1989; 86: 2018-20
69. Izumi-Hisha H, Ito Y, Sugkmoto K, et al. Age-related decrease in the number of hemopoietic stem cells and progenitors in senescence accelerated mice. Mech Ageing Dev 1990; 56: 89-97
70. Szakal AK, Kapasi ZF, Masuda A, et al. Follicular dendritic cells in the alternative antigen transport pathway: microenvironment, cellular events, age and retrovirus related alterations. Semin Immunol 1992; 4: 257-65
71. Beckman I, Dimopoulos K, Xaioning X, et al. T cell activation in the elderly: evidence for specific deficiencies in T cell/accessory cell interactions. Mech Ageing Dev 1990; 51: 265-76
72. McLachlan JA, Serkin CD, Morrey KM, et al. Antitumoral properties of aged human monocytes. J Immunol 1995; 154: 832-43
73. Itoh H, Abo T, Sugawara S, et al. Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes. J Immunol 1988; 141: 315-23
74. Ho S-P, Kramer KE, Ershler WB. Effect of host age upon interleukin-2-mediated anti-tumor responses in a murine fibrosarcoma model. Cancer Immunol Immunother 1990; 31: 146-50
75. Kutza J, Kaye D, Murasko DM. Basal natural killer cell activity of young versus elderly humans. J Gerontol 1991; 50A: B110-6
76. Kutza J, Murasko DM. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. Cell Immunol 1994; 155: 195-204
77. Kutza J, Kaye D, Murasko DM. Basal natural killer cell activity of young versus elderly humans. J Gerontol 1995; 50A: B110-6
78. Esposito D, Fassina G, Szabo P, et al. Chromosomes of older humans are more prone to aminopterin-induced breakage. Proc Natl Acad Sci U S A 1989; 86: 1302-6
79. Akiyama M, Shou O-L, Kusunoki Y, et al. Age and dose related alteration of in vitro mixed lymphocyte culture response of blood lymphocytes from A-bomb survivors. Radiat Res 1989; 117: 26-34
80. Mayer PJ, Lange CS, Bradley MO, et al. Age-dependent decline in rejoining of X-ray-induced DNA double-strand breaks in normal human lymphocytes. Mutat Res 1989; 219: 95-100
81. Melaragno MI, Smith MdeA. Sister chromatid exchange and proliferation pattern in lymphocytes from newborns, elderly subjects and in premature aging syndromes. Mech Ageing Dev 1990; 54: 43-53
82. Goodwin JS, Webb DR. Regulation of the immune response by prostaslandins: a critical review. Clin Immunol Immunopathol 1981; 15: 116-32
83. Goodwin JS. Changes in lymphocyte sensitivity to prostaglandin E, histamine, hydrocortisone, and X-irradiation with age: studies in a healthy elderly population. Clin Immunol Immunopathol 1982; 25: 243-51
84. Hayek MG, Meydani S, Meydani M, et al. Age differences in eicosanoid production of mouse splenocytes: effects on mitogen-induced T cell proliferation. J Gerontol 1994; 49: B197-207
85. Benharka AA, Wu D, Han SN, et al. Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reversed by the dietary antioxidant vitamin E. Mech Ageing Devel 1997; 93: 59-77
86. Riancho JA, Zarrabeitia MT, Amado JA, et al. Age-related differences in cytokine secretion. Gerontology 1994; 40: 8-12
87. Yoshikawa T, Suzuki H, Sugiyama E, et al. Effects of prostaglandin EI on the production of IgM and IaG class anti-dsDNA antibodies in NZBA/W F1 mice. J Rheum 1993; 20: 1701-6
88. Negoro S, Hara H, Miyata S, et al. Mechanisms of age-related decline in antigen-specific Tcell proliferative response: IL-2 receptor expression and recombinant IL-2 induced proliferative response of purified Tac-positive T cells. Mech Ageing Dev 1986; 36: 223-41
89. McElhaney JE, Beattie BL, Devine R, et al. Age-related decline in interleukin 2 production in response to influenza vaccine. J Am Geriatr Soc 1990; 38: 652-8
90. Vissinga C, Hertogh-Huijbregts A, Rozing J, et al. Analysis of the age-related decline in alloreactivity of CD4+ and CD8+ T cells in CBA/RIJ mice. Mech Ageing Dev 1990; 51: 179-94
91. Hara H, Tanaka T, Negoro S, et al. Age-related changes of expression of IL-2 receptor subunits and kinetics of IL-2 internalization in T cells after mitogenic stimulation. Mech Ageing Dev 1988; 45: 167-75
92. Nagel JE, Chopra RK, Powers DC, et al. Effect of age on the human high affinity interleukin 2 receptor of phytohaemagglutinin stimulated peripheral blood lymphocytes. Clin Exp Immunol 1989; 75: 286-91
93. Goonewardene IM, Murasko DM. Age associated changes in mitogen induced proliferation and cytokine production by lymphocytes of the long-lived brown Norway rat. Mech Ageing Dev 1993; 71: 199-212
94. Ajitsu S, Mirabella S, Kawanishi H. In vivo immunologic intervention in age-related T cell defects in murine gut-associated lymphoid tissues by IL-2. Mech Ageing Dev 1990; 54: 163-83
95. Hobbs MV, Ernst DN, Torbett BE, et al. Cell proliferation and cytokine production by CD4+ cells from old mice. J Cell Biochem 1991; 46: 312-20
96. Wu W, Pahlavani M, Cheung HT, et al. The effect of aging on the expression of interleukin 2 messenger ribonucleic acid. Cell Immunol 1986; 100: 224-31
97. Bradley SF, Vibhagool A, Kunkel SL, et al. Monokine secretion in aging and protein malnutrition. J Leukoc Biol 1989; 45: 510-4
98. Molteni M, Della Bella S, Mascagni B, et al. Secretion of cytokines upon allogeneic stimulation: effect of aging. J Biol Regul Homeost Agents 1994; 8: 41-7
99. Udhayakumar V, Subbarao B, Seth A, et al. Impaired T cell-induced T cell-T cell interaction in aged mice. Cell Immunol 1988; 116: 299-307
100. Thoman ML, Keogh EA, Weigle WO. Response of aged T and B cells to interleukin-4. Aging Immunol Infect Dis 1988/1989; 1: 245-53
101. Li SP, Miller RA. Age-associated decline in IL-4 production by murine T lymphocytes in extended culture. Cell Immunol 1993; 151: 187-95
102. Dobber R, Tielemans M, Nagelkerken L. The in vivo effects of neutralizing antibodies against IFN-gamma, IL-4, or IL-10 on the humoral immune response in young and aged mice. Cell Immunol 1995; 160: 185-92
103. Burns EA, l'Hommedieu GD, Cunning J, et al. Effects of interleukin 4 on antigen-specific antibody synthesis by lymphocytes from old and young adults. Lymphokine Cytokine Res 1994; 13 (4): 227-31
104. Candore G, Di Lorenzo G, Melluso M, et al. Gamma-interferon, interleukin-4 and interleukin-6 in vitro production in old subjects. Autoimmunity 1993; 16: 275-80
105. Nagelkerken L, Hertogh-Huijbregts A, Dobber R, et al. Age-related changes in lymphokine production related to a decreased number of CD45RBhi CD4+ T cells. Eur J Immunol 1991; 21: 273-81
106. Kutza J, Jurasko DM. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. Cell Immunol 1994; 155: 195-204
107. Krishnaraj R, Bhooma T. Cytokine sensitivity of human NK cells during immunosenescence: 2. IL-2-induced interferon gamma secretion. Immunol Lett 1996; 50: 59-63
108. Caruso C, Candore G, Cigna D, et al. Cytokine production pathway in the elderly. Immunol Res 1996; 15: 84-90
109. Faist E, Markewitz A, Fuchs D, et al. Immunomodulatory therapy with thymopentin and indomethacin: successful restoration of interleukin-2 synthesis in patients undergoing major surgery. Ann Surg 1991; 214: 264-73
110. Chopra RK, Holbrook NJ, Powers DC, et al. Interleukin 2, interleukin 2 receptor, and interferon-gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. Clin Immunol Immunopathol 1989; 53: 297-308
111. Daynes RA, Aranco BA, Ershler WB, et al. Altered regulation of IL-6 production with normal aging. J Immunol 1993; 150: 5219-30
112. Ershler WB. Interleukin-6: acytokine for gerontologists. J Am Geriatr Soc 1993; 41: 176-81
113. Sothern RB, Roitman-Johnson B, Kanabrocki EL, et al. Circadian characteristics of circulating interleukin-6 in men. J Allergy Clin Immunol 1995; 95: 1029-35
114. Liao Z, Caucino JA, Schniffer SM, et al. Increased urinary cytokine levels in the elderly. Aging Immunol Infect Dis 1993; 4: 139-53
115. Foster KD, Conn CA, Kluger MJ. Fever, tumor necrosis factor and interleukin-6 in young, mature and aged Fischer 344 rats. Am J Physiol 1992; 262: R211-5
116. Clark JA, Peterson TC. Cytokine production and aging: over-production of IL-8 in elderly males in response to lipopolysaccharide. Mech Ageing Dev 1994; 77: 127-39
117. Goodwin JS. Decreased immunity and increased morbidity in the elderly. Nutr Rev 1995; 53: S41-6
118. Bender BS, Nagel JE, Adler WH, et al. Absolute peripheral blood lymphocyte counts and subsequent mortality of elderly men. J Am Geriatr Soc 1986; 34: 649-54
119. Ferguson FG, Wikby A, Maxson P, et al. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol 1995; 50: B378-82
120. Wayne S, Rhyne R, Garry P, et al. Cell mediated immunity as a predictor of morbidity and mortality in the aged. J Gerontol 1990; 45: 45-9
121. Belch JJ. The relationship between while blood cells and arterial disease. Curr Opin Lipidol 1994; 5: 440-6
122. Clarkson RB, Alexander NJ. Long term vasectomy: effects on the occurrence and extent of atherosclerosis in rhesus monkeys. J Clin Invest 1980; 65: 15-25
123. Ansbacher R, Keung-Yeung K, Wurster JC. Sperm antibodies in vasectomized men. Fertil Steril 1972; 23: 640-3
124. Minick CR, Murphy GE, Campbell WG. Experimental induction of athero-arteriosclerosis by the synergy of allergic injury to arteries and lipid rich diet. J Exp Med 1966; 124: 635-52
125. Howard AN, Paterski J, Bowyer DE, et al. Atherosclerosis induced in hypercholesterolemic baboons by immunologic injury. Atherosclerosis 1971; 14: 17-29
126. Geng YJ, Holm J, Nygren S, et al. Expression of the macrophage scavenger receptor in atheroma: relationship to immune activation and the T-cell cytokine interferon-gamma. Arterioscler Thromb Vasc Biol 1995; 15: 1995-2002
127. Shimokama T, Haraoka S, Watanabe T. Morphological fate and sequelae of human atherosclerosis: evaluation of immune mechanisms in atherogenesis through immunohistological and ultrastructural analysis. Pathol Int 1995; 45: 801-14
128. Mackay IR, Whittingham SE, Mathews JD. The immuno-epidemiology of aging. In: Makinodan T, Yunis E, editors. Immunology and aging. New York: Plenum Press, 1977: 35-50
129. Beeson PB. Age and sex associations of 40 autoimmune diseases. Am J Med 1994; 96: 457-62
130. Salvarani C, Gabriel SE, O'Fallon WM, et al. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995; 123: 192-4
131. Goodwin JS. Progress in gerontology: polymyalgia rheumatica and temporal arteritis. J Am Geriatr Soc 1992; 40: 515-25
132. Baldursson O, Steinsson K, Bjornsson J, et al. Giant cell arteritis in Iceland: an epidemiologic and histopathologic analysis. Arthritis Rheum 1994; 37: 1007-12
133. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996; 156: 1097-100
134. Stratta P, Segoloni GP, Canavese C, et al. Incidence of biopsyproven primary glomerulonephritis in an Italian province. Am J Kidney Dis 1996; 27: 631-9
135. Simon P, Ramee MP, Autuly V, et al. Epidemiology of primary glomerular diseases in a French region: variations according to period and age. Kidney Int 1994; 46: 1192-8
136. Schon F, Drayson M, Tompson RA. Myasthenia gravis and elderly people. Age Ageing 1996; 25: 56-8
137. Wallace WA, Schofield JA, Lamb D, et al. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. Thorax 1994; 49: 1139-45
138. Wallace WA, Roberts SN, Caldwell H, et al. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. Thorax 1994; 49: 218-22
139. Prior C, Haslam PL. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases. Clin Exp Immunol 1992; 88: 280-7
140. Ma JY, Borch K, Mardh S. Human gastric H,K-adenosine triphosphatase beta-subunit is a major autoantigen in atrophic corpus gastritis: expression of the recombinant human glycoprotein in insect cells. Scand J Gastroenterol 1994; 29: 790-4
141. Martinez-Taboada VM, Goronzy JJ, Weyand CM. Clonally expanded CD8 T cells in patients with polymyalgia rheumatica and giant cell arteritis. Clin Immunol Immunopathol 1996; 79: 263-70
142. Macchioni P, Boiardi L, Salvarani C, et al. Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis. Br J Rheum 1993; 32: 666-70
143. Yi Q, He W, Matell G, et al. T and B lymphocytes reacting with the extracellular loop of the beta 2-adrenergic receptor (beta 2AR) are present in the peripheral blood of patients with myasthenia gravis. Clin Exp Immunol 1996; 103: 133-40
144. Ofosu-Appiah W, Mokhtarian F, Shirazian D, et al. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes. J Lab Clin Med 1994; 124: 231-41
145. Egan JJ, Stewart JP, Hasleton PS, et al. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 1995; 50: 1234-9
146. Ma JY, Borch K, Sjostrand SE, et al. Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol 1994; 29: 961-5
147. Burns EA, Goodwin JS. Immunology and infectious disease. In: Cassel CK, Riesenberg DE, Sorensen LB, editors. Geriatric medicine. 2nd ed. New York: Springer-Verlag, 1990: 312-29
148. Sullivan KM, Monto AS, Longini Jr IM. Estimates of the US health impact of influenza. Am J Public Health 1993; 83: 1712-6
149. Fagiolo U, Amadori A, Cozzi E, et al. Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging 1993; 5: 451-8
150. Ben-Yehuda A, Ehleiter D, Hu AR, et al. Recombinant vaccinia virus expressing the PR/8 influenza hemagglutinin gene overcomes the impaired immune response and increased susceptibility of old mice to influenza infection. J Infect Dis 1993; 168: 352-7
151. Kutza J, Gross P, Kaye D, et al. Natural killer cell cytotoxicity in elderly humans after influenza immunization. Clin Diagn Lab Immunol 1996; 3: 105-8
152. Swenson CD, Cherniack EP, Russo C, et al. IgD-receptor up-regulation on human peripheral blood T cells in response to IgD in vitro or antigen in vivo correlates with the antibody response to influenza vaccination. Eur J Immunol 1996; 26: 340-4
153. Remarque EJ, van Beek WC, Ligthart GJ, et al. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing home residents by the use of high-dose vaccines. Vaccine 1993; 11: 649-54
154. Gross PA, Quinnan GV, Rodstein M, et al. Association of influenza immunization with reduction in mortality in an elderly population. Arch Intern Med 1988; 148: 562-5
155. Arden NH, Patriarca PA, Kendal AP. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. In: Kendal AP, Patriarca PA, editors. Options for the control of influenza. New York: Alan R. Liss Inc., 1986: 155-68
156. Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1997; 46S: 1-20
157. Dunlap NE, Ballinger S, Reed T, et al. The use of monozygotic and dizygotic twins to estimate the effects of inheritance on the levels of immunoglobulin isotypes and antibodies to phosphocholine. Clin Immunol Immunopathol 1993; 66: 176-80
158. Nicoletti C. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen. Exp Mol Pathol 1995; 62: 99-108
159. Borghesi C, Nicoletti C. Increase of cross(auto)-reactive antibodies after immunization in aged mice: a cellular and molecular study. Int J Exp Pathol 1994; 75: 123-30
160. Stein BE. Adult vaccinations: protecting your patients from avoidable illness. Geriatrics 1993; 48: 46, 49-52, 55
161. Sims RV, Steinmann WC, McConville JH, et al. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988; 108: 653-7
162. Sharma N, Trubuhovich R, Thomas MG. Tetanus in Auckland: a preventable disease. N Z Med J 1994; 107: 82-4
163. Zuber PL, Schierz A, Arestegui G, et al. Tetanus in Switzerland 1980-1989. Eur J Epidemiol 1993; 9: 617-24
164. Gergen PJ, McQuillan TM, Kiely M, et al. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995; 332: 761-6
165. Knight AL, Richardson JP. Management of tetanus in the elderly. J Am Board Fam Pract 1992; 5: 43-9
166. Prevots R, Sutter RW, Strebel PM, et al. Tetanus surveillance - United States, 1989-1990. MMWR CDC Surveill Summ 1992; 41: 1-9
167. Ballestra DJ, Littenberg B. Should adult tetanus immunization be given as a single vaccination at age 65? A cost-effectiveness analysis. J Gen Intern Med 1003; 8: 405-12
168. Lichlenhan JB, Kellerman RD, Richards JF. Tetanus: a threat to elderly patients. Postgrad Med 1992; 92: 59-60, 65-7, 70-2
169. Stead WW, Lofgren JP, Warren E, et al. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985; 312: 1483-7
170. Stead WW, To T. The significance of the tuberculin skin test in elderly persons. Ann Intern Med 1987; 107: 837-42
171. Cooper AM, Callahan JE, Griffin JP, et al. Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis. Infect Immunol 1995; 63: 3259-65
172. Orme IM, Griffin JP, Roberts AD, et al. Evidence for a defective accumulation of protective T cells in old mice infected with Mycobacterium tuberculosis. Cell Immunol 1993; 147: 222-9
173. Orme IM. Mechanisms underlying the increased susceptibility of aged mice to tuberculosis. Nutr Rev 1995; 53: S35-40
174. Orme IM. Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J Immunol 1988; 140: 3589-93
175. Orme IM. The response of macrophages from old mice to Mycobacterium tuberculosis and its products. Aging Immunol Infect Dis 1993; 4: 187-95
176. Ragozzino MW, Melton III LJ, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine 1982; 61: 310-6
177. Donahue JG, Choo PW, Manson JE, et al. The incidence of herpes zoster. Arch Intern Med 1995; 155: 1605-9
178. Burke BL, Steele RW, Beard OW, et al. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982; 142: 291-3
179. Ragozzino MW, Melton III LJ, Kurland LT, et al. Risk of cancer after herpes zoster: a population-based study. N Engl J Med 1982; 307: 393-7
180. Lee JJ, Gauci CA. Postherpetic neuralgia: current concepts and management. Br J Hosp Med 1994/1995; 52: 565-7
181. Whitley RJ. Therapeutic approaches to varicella-zoster virus infections. J Infect Dis 1992; 166 Suppl. 1: S51-7
182. Kainer M, Mills J. Treatment of herpes simplex and varicella zoster infections. Aust Fam Physician 1994; 23: 2157-61, 2164-6
183. Beutner KR, Friedman DJ, Forszpaniak C, et al. Valacyclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39: 1546-53
184. Takahashi M. Current status and prospects of live varicella vaccine. Vaccine 1992; 10: 1007-14
185. Davies J, Hallworth JA, McLeish P, et al. Characterization and immunogenicity of a candidate subunit vaccine against varicella-zoster virus. Med Microbiol Immunol 1994; 183: 105-17
186. Gallo RC, Wong-Staal F. A human T-lymphotrophic retrovirus (HTLV-III) as the cause of AIDS. Ann Intern Med 1985; 103: 679-89
187. First 500,000 AIDS cases-United States, 1995. MMWR Morb Mortal Wkly Rep 1995; 44: 849-53
188. Adler WH, Nagel JE. Acquired immunodeficiency syndrome in the elderly. Drugs Aging 1994; 4: 410-6
189. Stall R, Catania J. AIDS risk behaviors among late middle-aged and elderly Americans. Arch Intern Med 1994; 154: 57-63
190. Steel M. IVth international AIDS conference. Lancet 1988; II: 54-5
191. Darby SC, Ewart DW, Giangrande PL, et al. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet 1996; 347: 1573-9
192. Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res 1970; 13: 1-27
193. Thomas L. Reactions to homologous tissue antigens in relation tohypersensitivity. In: Lawrence HS, editor. Cellular and humoral aspects of the hypersensitivity states. New York: Hoeber-Harper, 1959: 529-32
194. Gatti RA, Good RA. Aging, immunity and malignancy. Geriatrics 1970; 25: 158-68
195. Fraumeni JF, Hoover RN, Devesa SS, et al. Epidemiology of cancer. In: DeVita Jr VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. Philadelphia: Lippincott, 1993: 150-81
196. Newell GR, Spitz MR, Sider JG. Cancer and age. Semin Oncol 1989; 16: 3-9
197. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988; 319: 525-32
198. Pike MC. Age-related factors in cancer of the breast, ovary and endometrium. J Chronic Dis 1987; 40 Suppl. 2: S59-69
199. Cantor KP, Fraumeni JF. Distribution of non-Hodgkin's lymphoma in the United States between 1950 and 1975. Cancer Res 1980; 40: 2645-50
200. Ershler WB. The influence of an aging immune system on cancer incidence and progression. J Gerontol 1993; 48: B3-7
201. Ader R, Cohen N. Conditioned immunopharmacologic responses. In: Ader R, editor. Psychoneuroimmunology. Orlando (FL): Academic Press Inc., 1981: 281-317
202. Borysenko M, Borysenko J. Stress, behavior and immunity: animal models and mediating mechanisms. Gen Hosp Psychiatry 1982; 4: 59-67
203. Rosenberg LT, Coe CL, Levine S. Complement levels in the squirrel monkey. Lab Anim Sci 1982; 32: 371-2
204. Minter RE, Patterson-Kimball C. Life events and illness onset: a review. Psychosomatics 1978; 19: 334-9
205. Glaser R, Thorn BE, Tarr KL, et al. Effects of stress on methyltransferase synthesis: an important DNA repair enzyme. Health Psychol 1985; 4: 403-12
206. Thomas PD, Goodwin JM, Goodwin JS. Effect of social support on stress-related changes in cholesterol level, uric acid level and immune function in an elderly sample. Am J Psychiatry 1985; 142: 735-7
207. Bartoloni C, Guidi L, Antico L, et al. Psychological status and immunological parameters of institutionalized aged. Panminerva Med 1991; 33: 164-9
208. Glaser R, Kiecolt-Glaser JK, Speicher CE, et al. The relationship of stress and loneliness and changes in herpes virus latency. J Behav Med 1985; 8: 249-60
209. Glaser R, Pearson GR, Bonneau RH, et al. Stress and the memory T cell response to the Epstein-Barr virus in healthy medical students. Health Psychol 1993; 12: 435-42
210. Kielcolt-Glaser JK, Glaser R, Gravenstein S, et al. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci U S A 1996; 93: 3043-7
211. Kiecolt-Glaser JK, Marucha PT, Malarkey WH, et al. Slowing of wound healing by psychological stress. Lancet 1995; 346: 1194-6
212. Fabris N. A neuroendocrine-immune theory of aging. Int J Neurosci 1990; 51: 373-5
213. Song L, Kim YH, Chopra RK, et al. Age-related effects in T cell activation and proliferation. Exp Gerontol 1993; 28: 313-21
214. Lewis V, Twomey J, Bealmear P, et al. Age, thymic function and circulating thymic hormone activity. J Clin Endocrinol Metab 1978; 47: 145-52
215. Hirokawa K, Utsuyama M, Kasai M, et al. Aging and immunity. Acta Pathol Jpn 1992; 42: 537-48
216. Effros RB, Casillas A, Walford RL. The effect of thymosin-1 immunity to influenza in aged mice. Aging Immunol Infect Dis 1988; 1: 31-40
217. Goso C, Frasca D, Doria G. Effect of synthetic thymic humoral factor (THF-gamma 2) on T cell activities in immunodeficient ageing mice. Clin Exp Immunol 1992; 87: 346-51
218. Frasca D, Adorini L, Doria G. Enhanced frequency of mitogen-responsive T cell precursors in old mice injected with thymosin alpha I. Eur J Immunol 1987; 17: 727-30
219. Cillari E, Milano S, Perego R, et al. Modulation of IL-2, IFN-gamma, TNF-alpha and IL-4 production in mice of different ages by thymopentin. Int J Immunopharmacol 1991; 14: 1029-35
220. Duchateau J, Servais G, Vreyens R, et al. Modulation of immune response in aged humans through different administration modes of thymopentin. Surv Immunol Res 1985; 4 Suppl. 1: 94-101
221. Ershler WB, Moore AL, Hacker MP, et al. Specific antibody synthesis in vitro: II. Age-associated thymosin enhancement of anti-tetanus antibody synthesis. Immunopharmacology 1984; 8: 69-77
222. Meroni PL, Barcellini W, Frasca D, et al. In vivo immunopotentiating activity of thymopentin in aging humans: increase of IL-2 production. Clin Immunol Immunopathol 1987; 42: 151-9
223. Cillari E, Milano S, Dieli M, et al. Thymopentin reduces the susceptibility of aged mice to cutaneous leishmaniasis by modulating CD4T-cell subsets. Immunology 1992; 76: 362-6
224. Reiter RJ. Pineal function during aging: attenuation of the melatonin rhythm and its neurobiological consequences. Acta Neurobiol Exp (Warsz) 1994; 54: S31-9
225. Lissoni P, Brivio O, Fumagalli L, et al. Immune effects of pre-operative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose IL-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients. J Biol Regul Homeost Agents 1995; 9: 31-3
226. Lissoni P, Barni S, Fossati V, et al. A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumour. Support Care Cancer 1995; 3: 194-7
227. Caroleo MC, Frasca D, Nistico G, et al. Melatonin: an immunomodulator in immunodeficient mice. Immunopharmacology 1992; 23: 81-9
228. Saito H, Inoue T, Fukatsu K, et al. Growth hormone and the immune response to bacterial infection. Hormone Res 1996; 45: 50-4
229. Auernhammer CJ, Feldmeier H, Nass R, et al. Insulin-like growth factor I is an independent coregulatory modulator of NK cell activity. Endocrinology 1996; 137: 5332-6
230. Bonello RS, Marcus R, Bloch D, et al. Effects of growth hormone and estrogen on T lymphocytes in older women. J Am Geriatr Soc 1996; 44: 1039-42
231. Swenson CD, Gottesman SR, Belsito DV, et al. Relationship between humoral immunoaugmenting properties of DHEAS and IgD-receptor expression in young and aged mice. Ann N Y Acad Sci 1995; 29: 249-58
232. Araneo BA, Woods II ML, Daynes RA. Reversal of the immunosenescent phenotype by DHEA: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis 1993; 167: 830-40
233. Danenberg HD, Ben-Yehuda A, Zakay-Rones Z, et al. DHEA treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine 1995; 13: 1445-8
234. Araneo B, Dowell T, Woods ML, et al. DHEAS as an effective vaccine adjuvant in elderly humans: proof-of-principle studies. Ann N Y Acad Sci 1995; 774: 232-48
235. Chandra RK. Nutrition is an important determinant of immunity in old age. Prog Clin Biol Res 1990; 326: 321-34
236. Burns EA, Goodwin JS. Aging: nutrition and immunity. In: Forse RA, Bell SJ, Blackburn GL, editors. Diet, nutrition and immunity. Boca Raton (FL): CRC Press, 1994: 57-72
237. Effros RB, Walford RL, Weindruch R, et al. Influences of dietary restriction on immunity to influenza in aged mice. J Gerontol 1991; 46: B142-7
238. Ershler WB, Sun WH, Binkley N, et al. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res 1993; 12: 225-30
239. Kemintz JW, Weindruch R, Roecker EB, et al. Dietary restriction of adult male rhesus monkeys: design, methodology, and preliminary findings from the first year of study. J Gerontol 1993; 48: B17-26
240. Chandra RK, Puri S. Nutritional support improves antibody response to influenza vaccine in the elderly. BMJ 1985; 291: 705-6
241. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 1992; 340: 1124-7
242. Rasmussen LB, Kiens B, Pedersen BK, et al. Effect of diet and plasma fatty acid composition on immune status in elderly men. Am J Clin Nutr 1994; 59: 572-7
243. Meydani M. Vitamin E. Lancet 1995; 345: 170-5
244. Meydani SN, Hayek M. Vitamin E and immune response. In: Chandra RK, editor. Nutrition and immunology. St John's (Newfoundland): ARTS Biomedical Publishers and Distributors, 1992: 105-28
245. Wu D, Meydani SN, Sastre J, et al. In vitro glutathione supplementation enhances interleukin-2 production and mitogenic response of peripheral blood mononuclear cells from young and old subjects. J Nutr 1994; 124: 655-63
246. Meydani SN, Barklund PM, Liu S, et al. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr 1990; 52: 557-63
247. Meydani SN, Meydani M, Blumberg JB, et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects: a randomised controlled trial. JAMA 1997; 277: 1380-6
248. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996; 88: 1550-9
249. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88: 1560-70
250. Goodwin JS, Bankhurst A, Murphy S, et al. Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin. J Clin Lab Immunol 1978; 1: 197-9
251. Hsia J, Tang T, Parrott M, et al. Augmentation of the immune response to influenza vaccine by acetylsalicylic acid: a clinical trial in a geriatric population. Methods Find Exp Clin Pharmacol 1994; 16: 677-83
252. Cueppens J, Rodriguez M, Goodwin JS. Nonsteroidal anti-inflammatory drugs inhibit the production of IgM rheumatoid factor in vitro. Lancet 1982; I: 528-31
253. Levin MJ, Murray M, Zerbe GO, et al. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis 1994; 170: 522-6
254. Levine M, Beattie BL, McLean DM. Comparison of 1 and 2-dose regimens of influenza vaccine for elderly men. Can Med Assoc J 1987; 137: 722-6
255. Powers DC, Manning MC, Hanscome PJ, et al. Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in the elderly. J Infect Dis 1995; 172: 1103-7
256. Bleackley RC. Split-virus influenza vaccines: do they provide adequate immunity in the elderly? J Gerontol 1994; 49: M37-13
257. Gorse GJ, Campbell MJ, Otto EE, et al. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine. J Infect Dis 1995; 172: 1-10
258. Pennebaker JW, Kiecolt-Glaser JK, Glaser R. Disclosure of traumas and immune function: health implications for psychotherapy. J Consult Clin Psychol 1988; 56: 239-45
259. Kiecolt-Glaser JK, Glaser R, Williger D, et al. Psychosocial enhancement of immunocompetence in a geriatric population. Health Psychol 1985; 4: 25-41